vs
Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $422.8M, roughly 1.2× EDGEWELL PERSONAL CARE Co). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -15.5%, a 22.4% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -11.6%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -16.0%).
The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
EPC vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $422.8M | $493.8M |
| Net Profit | $-65.7M | $33.7M |
| Gross Margin | 38.1% | — |
| Operating Margin | -4.5% | 9.9% |
| Net Margin | -15.5% | 6.8% |
| Revenue YoY | -11.6% | -1.7% |
| Net Profit YoY | -3028.6% | 10.5% |
| EPS (diluted) | $-1.41 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $422.8M | $493.8M | ||
| Q3 25 | $600.5M | $492.9M | ||
| Q2 25 | $627.2M | $468.8M | ||
| Q1 25 | $580.7M | $458.4M | ||
| Q4 24 | $415.1M | $502.4M | ||
| Q3 24 | $517.6M | $511.2M | ||
| Q2 24 | $647.8M | $504.3M | ||
| Q1 24 | $599.4M | $495.1M |
| Q4 25 | $-65.7M | $33.7M | ||
| Q3 25 | $-30.6M | $71.7M | ||
| Q2 25 | $29.1M | $39.3M | ||
| Q1 25 | $29.0M | $20.7M | ||
| Q4 24 | $-2.1M | $30.5M | ||
| Q3 24 | $8.8M | $19.4M | ||
| Q2 24 | $49.0M | $-153.0M | ||
| Q1 24 | $36.0M | $4.0M |
| Q4 25 | 38.1% | — | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 42.8% | — | ||
| Q1 25 | 44.1% | — | ||
| Q4 24 | 41.6% | — | ||
| Q3 24 | 41.1% | — | ||
| Q2 24 | 44.3% | — | ||
| Q1 24 | 43.1% | — |
| Q4 25 | -4.5% | 9.9% | ||
| Q3 25 | -4.2% | 13.8% | ||
| Q2 25 | 8.6% | 12.8% | ||
| Q1 25 | 10.1% | 7.0% | ||
| Q4 24 | 2.2% | 7.8% | ||
| Q3 24 | 3.9% | 6.6% | ||
| Q2 24 | 12.8% | -31.3% | ||
| Q1 24 | 11.7% | 3.2% |
| Q4 25 | -15.5% | 6.8% | ||
| Q3 25 | -5.1% | 14.5% | ||
| Q2 25 | 4.6% | 8.4% | ||
| Q1 25 | 5.0% | 4.5% | ||
| Q4 24 | -0.5% | 6.1% | ||
| Q3 24 | 1.7% | 3.8% | ||
| Q2 24 | 7.6% | -30.3% | ||
| Q1 24 | 6.0% | 0.8% |
| Q4 25 | $-1.41 | $0.40 | ||
| Q3 25 | $-0.65 | $0.84 | ||
| Q2 25 | $0.62 | $0.46 | ||
| Q1 25 | $0.60 | $0.24 | ||
| Q4 24 | $-0.04 | $0.37 | ||
| Q3 24 | $0.18 | $0.23 | ||
| Q2 24 | $0.98 | $-1.84 | ||
| Q1 24 | $0.72 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $375.2M |
| Total DebtLower is stronger | $1.5B | $570.5M |
| Stockholders' EquityBook value | $1.5B | $865.9M |
| Total Assets | $3.8B | $2.2B |
| Debt / EquityLower = less leverage | 1.03× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | $209.1M | $103.8M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | $1.5B | $570.5M | ||
| Q3 25 | $1.4B | $577.2M | ||
| Q2 25 | $1.4B | $583.9M | ||
| Q1 25 | $1.4B | $590.5M | ||
| Q4 24 | $1.4B | $597.1M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $1.5B | $865.9M | ||
| Q3 25 | $1.6B | $890.7M | ||
| Q2 25 | $1.6B | $833.8M | ||
| Q1 25 | $1.5B | $789.2M | ||
| Q4 24 | $1.5B | $764.9M | ||
| Q3 24 | $1.6B | $732.5M | ||
| Q2 24 | $1.6B | $706.5M | ||
| Q1 24 | $1.6B | $856.2M |
| Q4 25 | $3.8B | $2.2B | ||
| Q3 25 | $3.8B | $2.2B | ||
| Q2 25 | $3.8B | $2.1B | ||
| Q1 25 | $3.8B | $2.0B | ||
| Q4 24 | $3.7B | $2.2B | ||
| Q3 24 | $3.7B | $2.1B | ||
| Q2 24 | $3.7B | $2.0B | ||
| Q1 24 | $3.8B | $2.2B |
| Q4 25 | 1.03× | 0.66× | ||
| Q3 25 | 0.89× | 0.65× | ||
| Q2 25 | 0.88× | 0.70× | ||
| Q1 25 | 0.95× | 0.75× | ||
| Q4 24 | 0.97× | 0.78× | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-125.9M | $114.1M |
| Free Cash FlowOCF − Capex | $-137.5M | — |
| FCF MarginFCF / Revenue | -32.5% | — |
| Capex IntensityCapex / Revenue | 2.7% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $36.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-125.9M | $114.1M | ||
| Q3 25 | $74.1M | $137.3M | ||
| Q2 25 | $114.8M | $137.2M | ||
| Q1 25 | $45.1M | $-117.5M | ||
| Q4 24 | $-115.6M | $133.0M | ||
| Q3 24 | $-388.3M | $91.8M | ||
| Q2 24 | $101.2M | $107.0M | ||
| Q1 24 | $129.0M | $-125.2M |
| Q4 25 | $-137.5M | — | ||
| Q3 25 | $46.5M | — | ||
| Q2 25 | $99.3M | — | ||
| Q1 25 | $28.0M | — | ||
| Q4 24 | $-132.4M | — | ||
| Q3 24 | $-414.2M | — | ||
| Q2 24 | $88.6M | — | ||
| Q1 24 | $117.5M | — |
| Q4 25 | -32.5% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | -31.9% | — | ||
| Q3 24 | -80.0% | — | ||
| Q2 24 | 13.7% | — | ||
| Q1 24 | 19.6% | — |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 5.0% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 1.9% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | 3.95× | 3.49× | ||
| Q1 25 | 1.56× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | -44.13× | 4.72× | ||
| Q2 24 | 2.07× | — | ||
| Q1 24 | 3.58× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
